INmune Bio Inc. (INMB) Financials

INMB Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 57.0 million 18.9 million
2023-09-30 62.7 million 18.0 million
2023-06-30 69.7 million 19.1 million
2023-03-31 74.0 million 18.7 million

INMB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.4 million 1.9 million
2023-09-30 -4.3 million 1.9 million
2023-06-30 -3.2 million 1.9 million
2023-03-31 -1.1 million 1.7 million

INMB Net Income

No data available :(

INMB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 35.8 million - 516000
2023-09-30 41.8 million - 536000
2023-06-30 47.8 million 4.8 million 564000
2023-03-31 51.0 million 7.3 million 604000

INMB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 18.0 million
2023-09-30 18.0 million
2023-06-30 17.9 million
2023-03-31 17.9 million

INMB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 6.0 million 2.4 million -
2023-09-30 - 6.0 million 2.6 million -
2023-06-30 - 4.1 million 2.3 million -
2023-03-31 - 4.1 million 2.3 million -

INMB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 28000 -
2023-09-30 43000 -
2023-06-30 46000 -
2023-03-31 38000 -

INMB

Price: $11.57

52 week price:
6.50
14.74

Earnings Per Share: -1.67 USD

P/E Ratio: -8.37

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 49961

Market Capitalization: 219.9 million

Links: